You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 292 No. 19, November 17, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Statistics and Research Methods
 •Women's Health
 •Women's Health, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Isoflavones and Postmenopausal Women

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: I would like to raise some methodological concerns about the study by Dr Kreijkamp-Kaspers et al.1 First, their assumption that soy isoflavones are equipotent to conventional hormone therapy is in error. Their power analysis indicates that they should have been able to detect a 6.7% increase in bone mineral density (BMD) based on 200 participants. They should have used 2-directional hypothesis testing and calculated power based on their actual sample size and, given that this magnitude of increase is within the range previously reported for bisphosphonates,2 a 3% change in response to isoflavones over 1 year may have been more realistic. Second, the authors state that "adjustment for smoking history and baseline BMD did not change the results," but current smoking status and antihypertensive medication use should have been taken into account statistically.

Third, those participants who had more recently transitioned through menopause experienced better results in . . . [Full Text of this Article]

D. Lee Alekel, PhD
alekel@iastate.edu
Food Science & Human Nutrition
Human Metabolic Unit
Center for Designing Foods to Improve Nutrition
Iowa State University
Ames



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Isoflavones and Postmenopausal Women
Cesare R. Sirtori
JAMA. 2004;292(19):2336-2337.
EXTRACT | FULL TEXT  

Isoflavones and Postmenopausal Women
Dave N. Muanza, Alex Vasquez, John Cannell, and William P. Grant
JAMA. 2004;292(19):2337.
EXTRACT | FULL TEXT  

Isoflavones and Postmenopausal Women—Reply
Yvonne T. van der Schouw, Diederick E. Grobbee, Linda Kok, and Sanne Kreijkamp-Kaspers
JAMA. 2004;292(19):2337.
EXTRACT | FULL TEXT  

Effect of Soy Protein Containing Isoflavones on Cognitive Function, Bone Mineral Density, and Plasma Lipids in Postmenopausal Women: A Randomized Controlled Trial
Sanne Kreijkamp-Kaspers, Linda Kok, Diederick E. Grobbee, Edward H. F. de Haan, André Aleman, Johanna W. Lampe, and Yvonne T. van der Schouw
JAMA. 2004;292(1):65-74.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.